Metraipolis › archive › dc_c99fcab72a6a

Everolimus suppresses glucose transporter 3 membrane trafficking to improve therapeutic efficacy of umbilical cord blood-derived mesenchymal stem cell… — Europe PMC PMID:41904172

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41904172
DOI
10.1038/s41419-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-03T18:11:42.856Z
SHA-256 of the archived text
751666e7407db38891825505ae264b37fc967a3eb8cf4f41f57852a0aa933240
Stable URL of this page
https://metraipolis.com/documento/dc_c99fcab72a6a

How to cite

Everolimus suppresses glucose transporter 3 membrane trafficking to improve therapeutic efficacy of umbilical cord blood-derived mesenchymal stem cell… — Europe PMC PMID:41904172 — Europe PMC (en), https://europepmc.org/article/MED/41904172 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c99fcab72a6a (Metraipolis archive dc_c99fcab72a6a, sha256 751666e7407db38891825505ae264b37fc967a3eb8cf4f41f57852a0aa933240)
BibTeX
@misc{dcc99fcab72a6a,
  title = {Everolimus suppresses glucose transporter 3 membrane trafficking to improve therapeutic efficacy of umbilical cord blood-derived mesenchymal stem cell… — Europe PMC PMID:41904172},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41904172},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c99fcab72a6a; sha256 751666e7407db38891825505ae264b37fc967a3eb8cf4f41f57852a0aa933240},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41904172. Agents can read the archived copy with the MCP tool read_document.